NO20080722L - Anvendelse av 4-(3,4-dijklorfenyl)-1,2,3,4-tetrahydronaftalen-1-ylamin for behandling av kreft - Google Patents

Anvendelse av 4-(3,4-dijklorfenyl)-1,2,3,4-tetrahydronaftalen-1-ylamin for behandling av kreft

Info

Publication number
NO20080722L
NO20080722L NO20080722A NO20080722A NO20080722L NO 20080722 L NO20080722 L NO 20080722L NO 20080722 A NO20080722 A NO 20080722A NO 20080722 A NO20080722 A NO 20080722A NO 20080722 L NO20080722 L NO 20080722L
Authority
NO
Norway
Prior art keywords
treatment
tetrahydronaphthalen
ylamine
dichlorophenyl
cancer
Prior art date
Application number
NO20080722A
Other languages
English (en)
Norwegian (no)
Inventor
Fabrice Balavoine
Frederic Revah
Marius Tuijnder
Robert Amson
Adam Telerman
Original Assignee
Anceris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anceris filed Critical Anceris
Publication of NO20080722L publication Critical patent/NO20080722L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20080722A 2005-07-12 2008-02-08 Anvendelse av 4-(3,4-dijklorfenyl)-1,2,3,4-tetrahydronaftalen-1-ylamin for behandling av kreft NO20080722L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0507480A FR2888506A1 (fr) 2005-07-12 2005-07-12 Utilisation de la 4-(3,4-dichloro-phenyl)-1,2,3,4- tetrahydro-naphtalen-1-ylamine pour le traitement du cancer
PCT/EP2006/064155 WO2007006797A1 (fr) 2005-07-12 2006-07-12 Utilisation de la 4-(3,4-dichloro-phenyl)-1,2,3,4-tetrahydro-naphtalen-1-ylamine pour le traitement du cancer

Publications (1)

Publication Number Publication Date
NO20080722L true NO20080722L (no) 2008-04-04

Family

ID=35925210

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080722A NO20080722L (no) 2005-07-12 2008-02-08 Anvendelse av 4-(3,4-dijklorfenyl)-1,2,3,4-tetrahydronaftalen-1-ylamin for behandling av kreft

Country Status (14)

Country Link
EP (1) EP1904045A1 (fr)
JP (1) JP2009501193A (fr)
KR (1) KR20080031748A (fr)
CN (1) CN101222917A (fr)
AU (1) AU2006268657A1 (fr)
CA (1) CA2614696A1 (fr)
FR (1) FR2888506A1 (fr)
IL (1) IL188685A0 (fr)
MA (1) MA29729B1 (fr)
NO (1) NO20080722L (fr)
RU (1) RU2008101268A (fr)
TN (1) TNSN08010A1 (fr)
WO (1) WO2007006797A1 (fr)
ZA (1) ZA200800500B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2816024T3 (en) * 2006-03-31 2017-10-30 Sunovion Pharmaceuticals Inc CHIRALE AMINER
FR2909283A1 (fr) * 2006-11-30 2008-06-06 Cerep Sa Produit de combinaison contenant de la n-desmethylsertraline, ou un de ses sels, et un agent antineoplasique pour le traitement du cancer
FR3071726B1 (fr) * 2017-09-29 2020-09-04 Univ Paris Sud Agents inhibant la proteine tctp pour le traitement de maladies proliferatives et de maladies infectieuses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996022085A1 (fr) * 1995-01-17 1996-07-25 Pfizer Inc. Utilisation de sertraline pour traiter les patients atteints du cancer
US20050013853A1 (en) * 2000-11-29 2005-01-20 Irit Gil-Ad Anti-proliferative drugs
BRPI0413679A (pt) * 2003-08-22 2006-10-24 Pharmacia Corp formulações de um inibidor seletivo da ciclooxigenase-2 e de um agente de modulação da serotonina para o tratamento da neoplasia

Also Published As

Publication number Publication date
WO2007006797A8 (fr) 2007-04-19
JP2009501193A (ja) 2009-01-15
FR2888506A1 (fr) 2007-01-19
EP1904045A1 (fr) 2008-04-02
IL188685A0 (en) 2008-12-29
KR20080031748A (ko) 2008-04-10
CN101222917A (zh) 2008-07-16
RU2008101268A (ru) 2009-08-20
TNSN08010A1 (fr) 2009-07-14
WO2007006797A1 (fr) 2007-01-18
MA29729B1 (fr) 2008-09-01
CA2614696A1 (fr) 2007-01-18
AU2006268657A1 (en) 2007-01-18
ZA200800500B (en) 2009-04-29

Similar Documents

Publication Publication Date Title
NO20091183L (no) Derivater av 4-(N-azacykloalkyl)-anilider, fremgangsmåte for fremstilling av slike forbindelser, preparater omfattende slike forbindelser samt anvendelse av slike forbindelser for forhindring eller behandling av sykdom
NO20074634L (no) Substituerte heterocykler og deres anvendelse som CHK1-, PDK1- og PAK-inhibitorer
DK1487444T3 (da) Anvendelse af pyridylamider som angiogeneseinhibitorer
WO2007095124A3 (fr) Derives, compositions de benzazole et procedes d'utilisation en tant qu'inhibiteurs de la kinase aurora
EA201690265A3 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
TW200738724A (en) Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
BRPI0709266B8 (pt) 5-(hidroximetileno e aminometileno) pirimidinas substituídas e composição farmacêutica que as compreende
NO20054083L (no) Nye sammenkoblede triazoloner og deres anvendelse
BRPI0915084B8 (pt) composto, e, composição farmacêutica
PL1899329T3 (pl) Pirymidyno-podstawione pochodne benzimidazolu jako inhibitory kinaz białkowych
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20090596L (no) Antivirale fosfinatforbindelser
CL2007002757A1 (es) Compuestos derivados de 1,2,4-triazina sustituida; composicion farmaceutica; y uso en el tratamiento o prevencion del reflujo gastroesofagico y ansiedad.
NO20074087L (no) Oralt disintegrert sammensetning av olanzapin eller donepezil
MX2009007345A (es) Compuestos con (fenil sustituido), con restos de propenal, sus derivados, actividad biologica y uso del mismo.
CL2009000906A1 (es) Compuestos derivados de 4-imidazolil y 4-triazolil de 2-(6-(4-cicloalquilpiperazin-1-il)pirimidin-4-il)-1h-pirazol-3(2h)ona inhibidores de hif-prolil-4-hidroxilasas; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de enfermedades cardiovasculares, renales y hematologicas.
NO20081014L (no) Sammensetninger
NO20091052L (no) Diaryleterderivater og anvendelser derav
WO2006100081A3 (fr) Derives d'indoxyle substitues, medicaments les contenant et leur utilisation
ATE499372T1 (de) Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel
NO20070980L (no) Selekterte kondenserte heterocykler og anvendelser derav
ATE429906T1 (de) Trockene aripiprazolformulierungen
WO2007066336A3 (fr) Derives chimiques de jasmonate, compositions pharmaceutiques et procedes d’utilisation correspondants
MX2009010176A (es) Derivados de aza-adamantano 4-substituidos y metodos de uso de los mismos.
TW200616977A (en) Enantiomers of selected fused heterocyclics and uses thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application